These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3381229)

  • 1. Intersubject variability in plasma theophylline levels after oral and intravenous administration in Jordanian patients with chronic obstructive pulmonary disease.
    Samara N; Sliman N; Sai'd S; Awidi A; Al-Turk W; Othman S; Khalaf R; Shaheen O
    Ther Drug Monit; 1988; 10(2):144-6. PubMed ID: 3381229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1982 Apr; 13(4):569-71. PubMed ID: 7066172
    [No Abstract]   [Full Text] [Related]  

  • 3. Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from an intravenous test dose.
    Horai Y; Ishizaki T; Sasaki T; Watanabe M; Kabe J
    Eur J Clin Pharmacol; 1982; 23(2):111-21. PubMed ID: 7140800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of theophylline and proxyphylline in the treatment of obstructive lung diseases in children: demands for new dosage routines].
    Holmen TL; Selvig K; Bjerve KS; Aas K; Rugstad HE
    Tidsskr Nor Laegeforen; 1980 Jan; 100(3):172-73. PubMed ID: 7385142
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of maintenance oral theophylline dosage using single oral doses in patients with obstructive airways disease.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1983 Nov; 16(5):511-6. PubMed ID: 6639837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of erythromycin stearate on serum theophylline concentration in patients with chronic obstructive lung disease.
    Stults BM; Felice-Johnson J; Higbee MD; Hardigan K
    South Med J; 1983 Jun; 76(6):714-8. PubMed ID: 6857302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Population pharmacokinetic analysis of theophylline: relationship between serum concentrations and clinical effects in therapeutic drug monitoring].
    Tanikawa K; Matsumoto Y; Matsuzaki T; Matsumoto M; Fukuoka M; Noguchi S; Goshima T
    Yakugaku Zasshi; 1999 Nov; 119(11):861-7. PubMed ID: 10590713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommended standard theophylline doses are inadequate in chronic obstructive pulmonary disease.
    Savage J; Wiseman IC
    S Afr Med J; 1987 Apr; 71(8):508-9. PubMed ID: 3563816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The disposition of theophylline in blood in chronic obstructive lung disease.
    Ebden P; Banks J; Peel T; Buss DC; Routledge PA; Spragg BP
    Ther Drug Monit; 1986; 8(4):424-6. PubMed ID: 3824427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of theophylline on cardiovascular performance in chronic obstructive pulmonary disease.
    Matthay RA
    Chest; 1985 Aug; 88(2 Suppl):112S-117S. PubMed ID: 3893923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease].
    Carvalho-Pinto RM; Terra Filho M; Cukier A; Santos SR; Verrastro C; Teixeira LR; Vargas FS
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline therapy. Titrating dosage requirements.
    Uden DL; Wyatt RA; Zaske DE
    Postgrad Med; 1984 Jun; 75(8):247-56. PubMed ID: 6728740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance oral theophylline therapy: suggested schedule in elderly patients.
    Krivoy N; Alroy G
    Respiration; 1980; 40(4):233-6. PubMed ID: 7221195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use of controlled-release theophylline in chronic airways obstruction.
    Dal Negro R; Turco P; Pomari C; Cordaro CI
    J Int Med Res; 1987; 15(6):391-6. PubMed ID: 3436486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable cardiovascular effects of theophylline in COPD.
    Matthay RA
    Chest; 1987 Jul; 92(1 Suppl):22S-26S. PubMed ID: 3297523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standards of laboratory practice: theophylline and caffeine monitoring. National Academy of Clinical Biochemistry.
    Pesce AJ; Rashkin M; Kotagal U
    Clin Chem; 1998 May; 44(5):1124-8. PubMed ID: 9590396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum theophylline levels with oral sustained release theophylline after transfer from intravenous aminophylline in patients with chronic lung disease.
    Silins RA; Butcher MA; Marlin GE
    Br J Clin Pharmacol; 1984 Oct; 18(4):645-7. PubMed ID: 6487509
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of theophylline in chronic obstructive lung disease.
    Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease: a study using stable isotope methodology during multiple oral dose administration.
    Vestal RE; Thummel KE; Musser B; Mercer GD
    Br J Clin Pharmacol; 1983 Apr; 15(4):411-8. PubMed ID: 6849776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.